News
WST
394.10
+1.51%
5.88
(WST) - Analyzing West Pharmaceutical Servs's Short Interest
West Pharmaceutical Servs's short percent of float has risen 8.42% since its last report. The company has 1.16 million shares sold short, which is 2.06% of all regular shares available for trading. Short interest is the number of shares that have been sold short but have not yet been covered.
Benzinga · 1d ago
Weekly Report: what happened at WST last week (0318-0322)?
Weekly Report · 3d ago
Weekly Report: what happened at WST last week (0311-0315)?
Weekly Report · 03/18 09:22
Friday Sector Laggards: Technology & Communications, Healthcare
NASDAQ · 03/15 18:35
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
NASDAQ · 03/14 16:07
May 17th Options Now Available For West Pharmaceutical Services (WST)
NASDAQ · 03/14 15:29
Strength Seen in West Pharmaceutical (WST): Can Its 5.7% Jump Turn into More Strength?
NASDAQ · 03/13 10:57
Is West Pharmaceutical Services (NYSE:WST) A Risky Investment?
West Pharmaceutical Services, Inc. Has US$206.8m in debt, but has more cash than liabilities. The company's balance sheet shows it has a decent-looking balance sheet. West Pharmaceutical Services has more liabilities than assets, but is a growing company with a solid growth rate. It is worth looking at how the company converts its earnings to free cash flow to assess its ability to manage debt. West pharmaceutical Services has debt but also has a solid balance sheet for the time being.
Simply Wall St · 03/12 10:22
Weekly Report: what happened at WST last week (0304-0308)?
Weekly Report · 03/11 09:22
Oppenheimer’s Buy vs. Sell ideas paired by each sector
Seeking Alpha · 03/04 20:45
Weekly Report: what happened at WST last week (0226-0301)?
Weekly Report · 03/04 09:23
West to Participate in Upcoming Investor Conferences
West Pharmaceutical Services, Inc. Will present at the Barclays 26th Annual Global Healthcare Conference in Miami, FL on March 12, 2024. The company is a global leader in innovative solutions for injectable drug administration. A live audio webcast of each event will be available on the company's website.
PR Newswire · 02/28 21:30
Why West Pharma Is Far From Done
West Pharmaceutical Services is a global manufacturer specializing in advanced containment and delivery systems for injectable drugs and healthcare products. The company has a strong focus on high-value products and strategic collaborations. West Pharmaceutical Services has returned 20% per year over the past 20 years. Despite current challenges, projected earnings growth suggests the potential for significant long-term returns.
Seeking Alpha · 02/28 04:36
Weekly Report: what happened at WST last week (0219-0223)?
Weekly Report · 02/26 09:24
Baron Funds Q3 2023 Letter From Ron Baron
Seeking Alpha · 02/25 14:00
West Pharm Svcs: Statement of changes in beneficial ownership of securities
Press release · 02/23 02:01
Buy Rating Affirmed for West Pharmaceutical Services on Robust Market Position and Growth Prospects
TipRanks · 02/22 07:05
West Pharmaceutical declares $0.20 dividend
Seeking Alpha · 02/20 12:35
More
Webull provides a variety of real-time WST stock news. You can receive the latest news about West Pharm Svcs through multiple platforms. This information may help you make smarter investment decisions.
About WST
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates through two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment solutions, and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.